Le Lézard
Classified in: Health
Subject: AWD

Jinfiniti Precision Medicine Named Among Top 20 Most Innovative Companies to Watch


LONDON, Jan. 27, 2022 /PRNewswire/ -- Based in Augusta, Georgia, USA, Jinfiniti Precision Medicine is dedicated to increasing human health and lifespan by providing a range of rapid screening services to biomedical research institutions, nutraceutical companies, the longevity industry, wellness clinics and consumers. This groundbreaking approach has led to the company being named in Business Worldwide Magazine's 2021 list of Top 20 Most Innovative Companies to Watch.

The list is a celebration of the trailblazing organizations that are changing the game in their respective industries and altering the corporate landscape. Whether it's healthcare, banking, industry, construction, energy or more, these companies are at the cutting edge of breakthrough technologies, innovation and modernized business structures. Those included have a shared goal of developing revolutionary products and technology that drive scalable business models and disrupt established industries and markets.

Jinfiniti is helping people around the world take an incredible step to not just being healthier, but to living longer than ever. The company was founded by Dr. Jin-Xiong She, who has gained worldwide recognition for his trailblazing work in his field. He is perhaps best known for his international TEDDY study, which focuses on screening hundreds of thousands of newborns to identify any predisposition to Type 1 Diabetes. He also teaches and conducts research across a wide range of areas including biomarker and drug development, longevity, genomics, proteomics and application of artificial intelligence in medicine.

With Dr. She at the helm, Jinfiniti is not only positioning itself as a global market leader, but an organisation that's redefining an entire sector. The philosophy at its heart is that prevention is better than cure, and that instead of responding to health issues that become apparent with age the best approach is to identify and address problems early on.

The supplement market is vast, with a predicted 2022 value of over $21 billion in the US alone. Conversely, there is still very little guidance available to help people understand which of those supplements are suitable for their individual genetics, so very few truly understand what lifestyle changes or supplements they really need the most. Jinfiniti has identified an opportunity to change the status quo and give people bespoke insight into their own body's needs, empowering them to make healthy choices.

Details on how Jinfiniti is maximising health span and determining the root causes of aging and age-related diseases can be found at the company website - Jinfiniti Precision Medicine

Further information about the Business Worldwide Magazine Innovation Awards can be found at https://www.bwmonline.com/awards/20-most-innovative-companies-to-watch-awards-2021/

About Business Worldwide Magazine

Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world. Our quarterly magazine and online news portal enable an established audience of corporate dealmakers to track the latest news, stories and developments affecting the international markets, corporate finance, business strategy and changes in legislation. This readership includes of CEO/CFO - Banks, Corporate Lawyers and Venture Capital/Private Equity Companies to name a few.

Contact:
David Jones
Awards Department
E: [email protected]


These press releases may also interest you

at 12:07
Getlabs, the nationwide leader in at-home diagnostics collection, has joined forces with Inocras, a leading AI-driven whole genome testing company that empowers patients with critical genetic insights for cancer and rare diseases....

at 12:06
Elegancia Healthcare W.L.L, a subsidiary of Estithmar Holding has entered into a second strategic agreement with...

at 12:05
Molecular Instruments, Inc. announced today that the Patents Court of the High Court of England and Wales has found two patents owned by Advanced Cell Diagnostics, Inc. (a Bio-Techne group company) to be invalid. In a 2022 lawsuit filed in the...

at 12:00
The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals...

at 12:00
Handl Health, a first-to-market AI platform built to help benefits consultants design and deliver affordable health benefits, today announced an oversubscribed $2.5M Seed fundraise initiated by Mucker Capital and Everywhere VC, with...

at 12:00
Dental Care Alliance (DCA) is exceptionally proud to announce that it has been named on not one, but two prestigious 'best of' lists by Newsweek: America's Greatest Workplaces for Job Starters 2024 and America's Greatest Workplaces for Mental...



News published on and distributed by: